Covid-19 roundup: US buys more of the only antibody that works against Omicron; BioNTech taps AI to detect new variants faster
GlaxoSmithKline and Vir’s monoclonal antibody sotrovimab is still the only mAb treatment that works against the Omicron variant, and the US on Tuesday boosted its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
